Dashboard
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
Poor long term growth as Net Sales has grown by an annual rate of 2.83% and Operating profit at 12.28% over the last 5 years
The company has declared Negative results for the last 3 consecutive quarters
Risky -
Stock DNA
Trading & Distributors
CNY 7,748 Million (Mid Cap)
NA (Loss Making)
NA
0.00%
-0.23
-5.54%
4.39
Total Returns (Price + Dividend) 
Innovation Medical Management Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News

Innovation Medical Management Hits Day High with Strong 5.62% Intraday Surge
Innovation Medical Management Co. has experienced notable stock activity, achieving a significant increase on October 15, 2025, despite broader market challenges. The company has shown impressive year-to-date performance, although it faces declining net sales and negative financial metrics, indicating ongoing operational difficulties.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot
Shareholding Compare (%holding) 
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 7.71% vs -5.97% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 119.42% vs 79.03% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 1.13% vs 13.18% in Dec 2023
YoY Growth in year ended Dec 2024 is -174.05% vs 53.40% in Dec 2023






